|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 186,800.00 KRW | +0.05% |
|
+1.91% | +3.61% |
| Dec. 11 | Celltrion USA, Inc. announced that it expects to receive $532.1 million in funding from Celltrion, Inc. | CI |
| Dec. 10 | Celltrion, Inc. announces Annual dividend | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5d. change | Varia. Jan 1. | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CELLTRION, INC. | Other Biotechnology & Medical Research | +0.05% | +1.91% | +3.61% | +5.47% | -38.86% | 27.66B |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- A068270 Stock
- Charts Celltrion, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
